Table 3.

Comparison of mean scores of each long-form Pro-VC-Be dimension between questionnaires completed before and after the workshop (n = 35).

	Score pre-session 1	Score difference between post-session 2 and pre-session 1
Dimension (/100)	Mean ± SD	Mean ± SD	p-value*	Effect size r
Confidence in vaccines	88.4 ± 10.6	1,5 ± 11.9	.14	0.25 [0.02;0.54]
Perceived risks of vaccines	16.2 ± 20.6	−3.8 ± 23.9	.10	0.28 [0.02;0.57]
Complacency	7.3 ± 13.7	−4.8 ± 13.3	.054	0.33 [0.05;0.58]
Perceived benefit/risk balance	89.2 ± 15.4	1.8 ± 21.5	.30	0.18 [0.01;0.47]
Collective responsibility	88.1 ± 13.8	−4.5 ± 18.7	.19	0.22 [0.01;0.52]
Proactive efficacy	55.3 ± 12,5	23.2 ± 18.7	<.0001	0.79 [0.66;0.87]
Commitment	74.6 ± 15.6	10.5 ± 20.5	.001	0.52 [0.24;0.75]
Perceived self-efficacy	36.0 ± 17.1	36.0 ± 25.8	<.0001	0.83 [0.73;0.87]
Openness to patients	47.8 ± 17.8	18.7 ± 17.0	<.0001	0.78 [0.65;0.86]
Trust in authorities	65.1 ± 25.4	9.5 ± 17.2	.01	0.44 [0.12;0.69]
Vaccine recommendation frequency (n = 26)	49.9 ± 18.0	3.1 ± 22.8	.67	0.08 [0.01;0.46]

*p-value from Wilcoxon-Pratt signed-rank tests.